When these ruptures occur in the abdomen, only 10% to 25% of patients survive to hospital discharge. Untreated, about one-third of these kinds of aneurysms will rupture.
Vancouver, BC (PRWEB) November 19, 2014
According to a recent report by iData Research (http://www.idataresearch.com), the peripheral vascular medical device market is estimated to be worth well over USD 1.8 billion by 2020. Broken down into 14 specific segments, the stent-graft market accounted over a quarter of the peripheral vascular device market. Stent-graft sales margins are high, but competition is fierce, with good reason.
“Stent-grafts are a non-surgical option for aortic aneurysms, the rupturing of which is a serious medical emergency,” explains Dr. Kamran Zamanian, CEO of iData. “When these ruptures occur in the abdomen, only 10% to 25% of patients survive to hospital discharge. Untreated, about one-third of these kinds of aneurysms will rupture.”
Aortic aneurysm treatment can involve significant risk; the proportion of surgeons performing vascular repair differs from country to country in Europe. This offers a particular challenge to manufacturers, who may have to adapt their sales strategy to regional circumstances. That said, with an average selling price of more than USD 10,000 per unit, revenues can be considerable. iData estimates that European stent-graft unit sales will exceed 40,000 by 2015.
Cook Medical vs Medtronic
While Cook Medical took the overall leading position in the peripheral vascular medical device market, Medtronic claimed first place for stent-graft revenues. However, Medtronic may have this lead challenged in the coming years. W.L. Gore held a close third position, and Lombard Medical’s new Aorfix product may claim additional market share.
Cook Medical’s PV product offerings are significantly more diverse than Medtronic’s, with Cook competing in five other markets in which Medtronic does not have a notable presence.
More on the European Peripheral Vascular Market
Peripheral vascular market forecasts in Europe include segments for PV stents, balloon catheters, atherectomy devices, chronic total occlusion, embolic protection devices, stent-grafts, surgical grafts, AV access thrombectomy devices, inferior vena cava filters, diagnostic and interventional catheters, standard and hydrophilic guidewires, introducer sheaths, vascular closure devices, and transcatheter embolization devices. iData’s in-depth market research report includes deeper segmentation, average selling prices, unit sales, and detailed competitor analyses.
Other leading competitors in the PV device market include Boston Scientific, Cordis, Covidien, Abbott Laboratories, C. R. Bard, St. Jude Medical, and Terumo. More than 40 other competitors have been considered in iData’s European peripheral vascular market calculations.
For more information
iData’s comprehensive report entitled Markets for Peripheral Vascular Devices includes the latest data, market analyses and competitor profiles for countries and regions across Europe, including Austria, Belgium, Denmark, Finland, France, Italy, Luxembourg, the Netherlands, Norway, Portugal, Spain, Sweden, Switzerland and the United Kingdom. This report provides a comprehensive analysis of the peripheral vascular device industry in Europe, including: Stents, Guidewires, Vascular Closure Devices, Stent-Grafts, and Transcatheter Embolics.
Get a full report synopsis or table of contents for this report here.
About iData Research
iData Research is an international market research and consulting group focused on providing market intelligence for medical device, dental and pharmaceutical companies. iData covers research in: hearing devices, cardiovascular, orthopedics and more.